Li Zhigang
李志刚
Areas of Expertise
Professional Biography
Dr. Li Zhigang is Director, Thoracic Surgery at Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai. Led the world's first RCT proving robotic esophagectomy achieves superior 5-year survival — unique among all solid tumor robotic trials.
Education & Training
- Medical and surgical training in thoracic surgery (China)
- Fellowship, European Society of Thoracic Surgeons (Francis Foundation Young Surgeon Training Center)
Awards & Certifications
- China's first robotic esophageal surgery clinical demonstration center designation
Leadership & Board Memberships
- Director, Department of Thoracic Surgery, Shanghai Chest Hospital
- Director, World's first TR500 Robotic Minimally Invasive Surgery Training Center for Esophageal Cancer
- Director, World's largest database for robot-assisted esophageal cancer surgery
Pioneering Contributions
Led the world's first prospective RCT proving robot-assisted minimally invasive esophagectomy (RAMIE) achieves superior 5-year survival (69.4% vs. 56.2%) — the only robot-related trial across all solid tumors to show statistically significant improvement in 5-year survival
Shanghai Chest Hospital: 2,600+ RAMIE procedures — #1 worldwide for single-center volume
Established the world's first TR500 Robotic Training Center for esophageal cancer surgery
International Patient Services
Full support for your journey to China
Medipath provides comprehensive support for international patients. Services include full English-speaking medical consultations, dedicated medical translation staff, and specialized assistance with medical visa applications to ensure a seamless healthcare journey.
English Consultations
Full English-speaking medical appointments
Medical Translation
Dedicated translation for all documentation
Visa Assistance
Medical visa application support